| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/28/2008 | EP1246925B1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 05/28/2008 | EP1196587B1 Antigenic meningococcal peptides |
| 05/28/2008 | EP1090127B1 Adh7 nucleotides |
| 05/28/2008 | EP1066315B1 Use of inhibitors of mammalian asparaginyl endopeptidase for modulating the immune system |
| 05/28/2008 | EP1017715B1 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest |
| 05/28/2008 | EP1009759B1 Carbohydrate crosslinked glycoprotein crystals |
| 05/28/2008 | EP1005485B1 Therapeutic pulmonary lavage with diluted surfactants |
| 05/28/2008 | EP0854927B1 Human dnase i variants |
| 05/28/2008 | CN101189335A Leptin antagonists |
| 05/28/2008 | CN101189334A 抗cd14抗体融合蛋白质 Anti-cd14 antibody fusion proteins |
| 05/28/2008 | CN101189263A Recombinant E-selectin made in insect cells |
| 05/28/2008 | CN101189262A Humanin receptor or humanin-like polypeptide receptor |
| 05/28/2008 | CN101189259A Follicle stimulating hormone superagonists |
| 05/28/2008 | CN101189258A A peptide ligand to impair cancer cell migration |
| 05/28/2008 | CN101189252A Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof |
| 05/28/2008 | CN101189025A Stabilized parathyroid hormone composition comprising parathyroid hormone, buffer and stabilizing agent |
| 05/28/2008 | CN101189024A Stabilised IL-21 compositions |
| 05/28/2008 | CN101189023A 监测和调制hgf/hgfr活性 Monitoring and modulation hgf / hgfr activity |
| 05/28/2008 | CN101189022A Adrenocorticotropic hormone analogs and related methods |
| 05/28/2008 | CN101189021A Compositions and methods for the control, prevention, and treatment of obesity and eating disorders |
| 05/28/2008 | CN101189020A Compositions for administering RNAIII-inhibiting peptides |
| 05/28/2008 | CN101189019A Peptide having anti-anxiety effect and method for screening thereof |
| 05/28/2008 | CN101188999A A pharmaceutical delivery system for deliverying active component dispersed in dispersion medium |
| 05/28/2008 | CN101188996A Surface-modified microparticles and methods of forming and using the same |
| 05/28/2008 | CN101188949A Egg-derived bone-strengthening composition |
| 05/28/2008 | CN101186940A Process for obtaining insulin or insulin derivatives having correctly bonded cystine bridges |
| 05/28/2008 | CN101186928A Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery |
| 05/28/2008 | CN101186923A CDNA sequence of coding perinereis albuhitensis grube protease and amino acid sequence thereof |
| 05/28/2008 | CN101186921A Novel gene Xsynuclein for xenopus laevis GRK family |
| 05/28/2008 | CN101186646A Application of king cobra toxin protease inhibitor and its derivatives |
| 05/28/2008 | CN101186637A Method for inhibiting influenza virus infection and medicament thereof |
| 05/28/2008 | CN101185762A Ciliary neurotrophic factors decorated by polyglycol polymer and preparation method thereof |
| 05/28/2008 | CN101185759A Anti-angiogene compositions and methods of use |
| 05/28/2008 | CN101185754A Novel MHC II associated peptides |
| 05/28/2008 | CN100390292C Adenovirus vector specific for cells expressing alpha fetoprotein and methods of use thereof |
| 05/28/2008 | CN100390286C Novel enzyme gene and its expression product |
| 05/28/2008 | CN100390282C Immunocytokines with modulated selectivity |
| 05/28/2008 | CN100390281C Method for preparing physiologically active IL-18 polypeptide |
| 05/28/2008 | CN100390280C Gene of expressing regeneration enhancement factor of recombined human liver in full lenght, and method for preparing regeneration enhancement factor of recombined human liver in full length, and use |
| 05/28/2008 | CN100390279C Altered polypeptides with increased half-life |
| 05/28/2008 | CN100390201C Fusion protein with reinforced erythrocytin activity in vivo |
| 05/28/2008 | CN100390200C Recombinant targeted fusion protein for treating acquired immunodeficiency syndrome |
| 05/28/2008 | CN100390197C Methods of conversion of interferson isoforms and products thereof |
| 05/28/2008 | CN100390196C Hybrid and tandem expression of neisserial proteins |
| 05/28/2008 | CN100390195C Modulators of function of FAS receptors and other proteins |
| 05/28/2008 | CN100390194C Low hemolytic antibacterial peptide and its application |
| 05/28/2008 | CN100389831C Gene engineering vaccine used for preventing pig cysticercosis and its preparation method |
| 05/28/2008 | CN100389829C Identification method of compound for inhibiting tumour injury and medicinal compositions containing said compound |
| 05/28/2008 | CN100389825C Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-CD20 antibodies |
| 05/28/2008 | CN100389822C Pyridoxal phosphate internally cross-linked hematoglobin nanocapsule and its preparing method |
| 05/28/2008 | CN100389821C Stabilized liquid polypeptide-containing pharmaceutical composition |
| 05/28/2008 | CN100389820C Therapeutic agent comprising botulinum neurotoxin |
| 05/28/2008 | CN100389773C Novel helicobacter pylori-binding substances and use thereof |
| 05/28/2008 | CA2569204A1 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl-d-tryptophan |
| 05/27/2008 | US7379820 Solution structure of RIP DD and uses thereof |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378507 for pharmaceuticals, diagnostics, biosensors and bioreactors; thrombolytic agents, interferons, interleukins, erythropoietins, colony stimulating factors, and cytokines; solid phase synthesis |
| 05/27/2008 | US7378506 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 05/27/2008 | US7378502 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 05/27/2008 | US7378500 below the kneecap in a diabetic subject; administering agonist of the non-proteolytically activated thrombin receptor |
| 05/27/2008 | US7378498 Protein encoded by a nucleic acid |
| 05/27/2008 | US7378497 Potassium channels and genes encoding these potassium channels |
| 05/27/2008 | US7378496 kits for prognosis and treatment regimen of a subject having or at risk for neuropsychiatric, neurological, neuromuscular, and immunological disorder |
| 05/27/2008 | US7378494 Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonist peptide |
| 05/27/2008 | US7378490 a cyclic dodecapeptide containing Arg, Asp, Ala, Glu, Ser, Gly, Ala; cyclic peptides serve as antigens for producing a neutralizing antibody capable of neutralizing HIV-1 virus infection via the second receptors called CXCR4 and CCR5 |
| 05/27/2008 | US7378488 for promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation |
| 05/27/2008 | US7378487 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 05/27/2008 | US7378485 A compound containing a polyamide backbone bearing a plurality of ligands that are individually bound to aza nitrogen atoms loacted within the backbone and atleast one ligand is a nucleobase, a DNA intercalator or nucleobase binder |
| 05/27/2008 | US7378445 Treatment of prostate cancer |
| 05/27/2008 | US7378422 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 05/27/2008 | US7378412 Pharmaceutical compounds |
| 05/27/2008 | US7378397 Peptide derivatives; thyrotropin-releasing hormone-degrading; brain and spinal injuries, central nervous system disorders |
| 05/27/2008 | US7378396 Therapeutic agents and methods for cardiovascular disease |
| 05/27/2008 | US7378395 Administering deletion mutant of a transforming growth factor beta super family member; deletion mutant has an ossification inhibiting mutation |
| 05/27/2008 | US7378394 Sustained-release microparticle preparation of human growth hormone and process for producing thereof |
| 05/27/2008 | US7378393 Recombinant anticoagulant proteins |
| 05/27/2008 | US7378392 Bone and cartilage inductive proteins |
| 05/27/2008 | US7378391 Cyclosporin alkyne analogues and their pharmaceutical uses |
| 05/27/2008 | US7378390 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
| 05/27/2008 | US7378389 Neurotoxic component has been purified from a botulinum toxin by fermenting a Clostridium botulinum to botulinum toxin type A; promotion of normal muscle growth |
| 05/27/2008 | US7378388 Method of utilizing neurotrophins to manipulate reproductive capacity |
| 05/27/2008 | US7378387 Method of suppressing immune response by reducing intracellular content of glutathione in macrophages and monocytes |
| 05/27/2008 | US7378386 inhibiting viral replication or infection by contacting a composition with a virally infected cell with a cell impervious cephalin-binding ligand or proteins; treating an animal with a viral infection; hepatitis, influenza, AIDS, viral pneumonia or respiratory disease |
| 05/27/2008 | US7378385 Role for GLP-1 to mediate responses to disparate stressors |
| 05/27/2008 | US7378384 X-Y-Thr-Trp-Asn-Gln-Met-Asn-Leu wherein X represents Ser, Ala, Abu, Arg, Lys, Orn, Cit, Leu, Phe, or Asn, and Y represents Tyr or Met; cysteine residue is substituted with a defined amino acid residue; cancer vaccines |
| 05/27/2008 | US7378276 Method of inducing memory B cell development and terminal differentiation |
| 05/27/2008 | US7378275 Canine IL-13 receptor alpha-1 subunit nucleic acid molecules |
| 05/27/2008 | US7378274 Regulatory nucleic acid for the ABC1 gene, molecules modifying its activity and therapeutic uses |
| 05/27/2008 | US7378253 Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells |
| 05/27/2008 | US7378251 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein |
| 05/27/2008 | US7378247 Tumor preferential polypeptide for use in the prevention treatment and diagnosis of cell proliferative disorders |
| 05/27/2008 | US7378234 Method for isolating hepatitis C virus peptides |
| 05/27/2008 | US7378099 Human papillomavirus polypeptides and immunogenic compositions |
| 05/27/2008 | US7378098 CXC chemokine receptor 4 agonist peptides |
| 05/27/2008 | US7378096 biodrugs comprising heat shock protein or glucose-regulated proteins complexed with immuogens including glycoproteins, her2/neu proteins or tuberculosis antigens, and carriers, used as anticarcinogenic agents |
| 05/27/2008 | US7378095 Methods of treating type I diabetes by blocking VEGF-mediated activity |
| 05/27/2008 | US7378091 Antibodies against carbonic anhydrase IX (CA IX) tumor antigen |
| 05/27/2008 | US7378090 Alleviation of the memory deficits and memory components of psychiatric dysfunctions by altering atypical PKM activity |
| 05/27/2008 | US7378089 Supplying suppressive genetic engineered cells; antiinflammatory agents |
| 05/27/2008 | US7378087 Method of enhancing an immune response |